Refine
Year of publication
Document Type
- Preprint (727)
- Article (545)
- Conference Proceeding (3)
- Working Paper (1)
Has Fulltext
- yes (1276)
Is part of the Bibliography
- no (1276)
Keywords
- Heavy Ion Experiments (21)
- Hadron-Hadron Scattering (14)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- Heavy-ion collision (6)
- Jets (6)
- HIV (5)
- ALICE experiment (4)
- Collective Flow (4)
- Heavy Ions (4)
- Heavy Quark Production (4)
- Quark-Gluon Plasma (4)
- breast cancer (4)
- ALICE (3)
- Jets and Jet Substructure (3)
- coronavirus (3)
- pp collisions (3)
- Beauty production (2)
- Breast cancer (2)
- COVID-19 (2)
- CRM (2)
- Charm physics (2)
- Diagnostik (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Früherkennung (2)
- Hepatitis C virus (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Mammakarzinom (2)
- Nachsorge (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- QCD (2)
- Quark Gluon Plasma (2)
- Quarkonium (2)
- Relativistic heavy-ion collisions (2)
- Richtlinie (2)
- Single electrons (2)
- biomarker (2)
- brain metastases (2)
- cirrhosis (2)
- diagnosis (2)
- follow‑up (2)
- guideline (2)
- guidelines (2)
- reference values (2)
- screening (2)
- stroke (2)
- 900 GeV (1)
- AA-amylodosis (1)
- ABC transporters (1)
- ACLF (1)
- ADHD (1)
- ALICE detector (1)
- APRI (1)
- ASAP (1)
- ATAD2 (1)
- ATPases (1)
- Abrasion (1)
- Adverse events (1)
- Alien (1)
- Alternating Phase Focusing (1)
- Analysis and statistical methods (1)
- Anti-nuclei (1)
- Antiretroviral therapy (1)
- Antiretrovirals (1)
- Antirheumatic agents (1)
- Artesunate (1)
- Atmospheric science (1)
- B cell subpopulations (1)
- BRCA1 (1)
- BRCA2 (1)
- BRD2 (1)
- BRD4 (1)
- BROMO-10 (1)
- Baryonic resonances (1)
- Beam dynamics simulation (1)
- Big Five (1)
- Biodiversity (1)
- Biogeographical representativeness (1)
- Boosted Jets (1)
- CD16 (1)
- CD56 (1)
- CDH13 (1)
- CLIF-C ACLF score (1)
- CLIF-C ACLF-R score (1)
- CVID (1)
- Calorimeters (1)
- Cancer (1)
- Cancer genetics (1)
- Cancer genomics (1)
- Central nervous system metastases (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charge fluctuations (1)
- Chemoradiotherapy (1)
- Chemorefractory advanced gastric cancer (1)
- Child (1)
- Child abuse (1)
- Children (1)
- Chronic kidney disease (1)
- Cirrhosis (1)
- Claims on land (1)
- Climate change (1)
- Clinical genetics (1)
- Clinical study (1)
- Clinical variation (1)
- Collective Flow, (1)
- Comparative effectiveness research (1)
- Comparison with QCD (1)
- Consensus (1)
- Continuous wave (1)
- Cytoskeleton (1)
- Data management (1)
- Data processing methods (1)
- Decision trees (1)
- Decontamination (1)
- Dental air (1)
- Dental implants (1)
- Depression (1)
- Dermatomyositis (1)
- Devic disease (1)
- Devic syndrome (1)
- Diagnosis (1)
- Diagnostic differentiation (1)
- Docetaxel (1)
- Drug therapy (1)
- EBV (1)
- Ecosystem integrity (1)
- Ecosystem services (1)
- Ecosystems (1)
- Elderly (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Emotions (1)
- Entomology (1)
- Environment (1)
- Ephrin-B2–EphB4 (1)
- Essential biodiversity variables (1)
- Europe (1)
- European Society for Immunodeficiencies (ESID) (1)
- Exosomes (1)
- Experimental models of disease (1)
- FIB-4 (1)
- FOLFIRI (1)
- FXIII deficiency (1)
- Factor XIII (1)
- Falciparum (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Fibrosis (1)
- Fibrotest (1)
- First site of metastatic disease (1)
- First-line combination antiretroviral therapy (1)
- Forensic examination (1)
- Forschung (1)
- Frailty (1)
- Freezeout (1)
- Gadobutrol (1)
- Gadopentate dimeglumine (1)
- General practitioners (1)
- Genetics research (1)
- Genomic instability (1)
- German PID-NET registry (1)
- Gleason Score (1)
- HBT (1)
- HBV (1)
- HCV (1)
- HER2 c-erbB2 (1)
- HER2-positive (1)
- HER2/neu (1)
- HIV-1 (1)
- HIV-RNA (1)
- HNO (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hals-Nasen-Ohren-Heilkunde (1)
- Hard Scattering (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ion (1)
- Heavy ions (1)
- Heavy-Ion Collision (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Heavy-ion detectors (1)
- Heavy-ion reactions (1)
- Hepatotoxicity (1)
- Hereditary breast and ovarian cancer (1)
- Human behaviour (1)
- Human well-being (1)
- Hyperons (1)
- Hypertension (1)
- IHC (1)
- IVDU (1)
- IgG substitution therapy (1)
- Immunology (1)
- Inclusive spectra (1)
- Intensity interferometry (1)
- Invariant Mass Distribution (1)
- Inverse kinematics (1)
- Ionisation energy loss (1)
- Isoscalar giant resonances (1)
- Jet Physics (1)
- Jet Substructure (1)
- LTER (1)
- Large detector systems for particle and astroparticle physics (1)
- Lehre (1)
- Linear accelerator (1)
- Liver diseases (1)
- Liver enzymes (1)
- Liver transplantation (1)
- Long-term ecological monitoring (1)
- Long‐term ecosystem research (1)
- MRI (1)
- MS (1)
- Malaria (1)
- Material budget (1)
- Mental health and psychiatry (1)
- MicroRNAs (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Molecular medicine (1)
- Molecular neuroscience (1)
- Mongolian spot (1)
- Monte Carlo (1)
- Multi-Parton Interactions (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multivariate analysis (1)
- Myanmar (1)
- NK cells (1)
- NMO-IgG (1)
- NSAIDs (1)
- Neoadjuvant radiochemotherapy (1)
- Neoadjuvant therapy (1)
- Neural network (1)
- Neuromyelitis optica (1)
- Nevus of Ito (1)
- Nevus of Ota (1)
- Noninferiority (1)
- Nonlinear beam dynamics (1)
- Nuclear modification factor (1)
- Nucleus (1)
- ORL (1)
- Observation (1)
- Oesophagogastric cancer oxaliplatin (1)
- Oldest-old (1)
- Osteoporosis (1)
- Otorhinolaryngology (1)
- PID prevalence (1)
- PYTHIA (1)
- Particle and Resonance Production (1)
- Pathological complete response (1)
- Pb–Pb (1)
- Performance of High Energy Physics Detectors (1)
- Peri-implantitis (1)
- Personalized medicine (1)
- Phylogenomics (1)
- Physiology (1)
- Plasmodium (1)
- Population genetics (1)
- Pre-treatment drug resistance mutations (1)
- Predictive markers (1)
- Predictive medicine (1)
- Production Cross Section (1)
- Properties of Hadrons (1)
- Proton (1)
- Proton–proton (1)
- Psychiatric disorders (1)
- Psychometrics (1)
- QGP (1)
- Quark Deconfinement (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Questionnaires (1)
- Quinine (1)
- Rapidity Range (1)
- Regression analysis (1)
- Relativistic heavy ion physics (1)
- Renal lesions (1)
- Research (1)
- Research infrastructure (1)
- Residency (1)
- Resolution Parameter (1)
- Rheumatoid arthritis (1)
- Rheumatology (1)
- SARS-CoV‑2 pandemic (1)
- SARS-CoV‑2-Pandemie (1)
- SF-36 (1)
- Severe malaria (1)
- Single muons (1)
- Site networks (1)
- Socio-ecology (1)
- Specialist training (1)
- Stentoplasty (1)
- Storage ring (1)
- Strangeness (1)
- Sunitinib (1)
- Sustainability (1)
- Systematic Uncertainty (1)
- T-DM1 (1)
- TR (1)
- Teaching (1)
- Thrombosis (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transient elastography (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Trigger (1)
- Triple negative (1)
- Triple-negative breast cancer (1)
- Tyrosine kinase inhibitor (1)
- University hospitals (1)
- Universitätskliniken (1)
- VEGF (1)
- Vector Boson Production (1)
- Vertebral augmentation (1)
- Vertebral body stenting (1)
- Vertebral fracture (1)
- Viral load (1)
- Virological failure (1)
- WHO-5 (1)
- Weiterbildung (1)
- X-ray crystallography (1)
- Xenon-based gas mixture (1)
- acoustic radiation force impulse imaging (1)
- acute-on-chronic liver failure (1)
- acute‐on‐chronic liver failure (1)
- advanced breast cancer (1)
- agreeableness (1)
- allogeneic transplantation (1)
- androgen receptor (1)
- angiopoietin-like 3 (ANGPTL3) (1)
- anti-retroviral agents (1)
- antibiotic resistance (1)
- antibiotics (1)
- antihormone therapy (1)
- aquaporin-4 (AQP4) antibody (1)
- asymptomatic (1)
- autoimmunity (1)
- binary nucleation (1)
- bioprinting (1)
- biosecurity (1)
- blood hiv rna (1)
- body-on-a-chip (1)
- bortezomib (1)
- bromodomain inhibitor (1)
- cART (1)
- cancer therapy (1)
- castration-resistant prostate cancer (1)
- cd4 count determination procedure (1)
- cerebrospinal fluid (1)
- chemotherapy (1)
- children (1)
- chromatin (1)
- circulation (1)
- clinical features (1)
- co-infection (1)
- complement system (1)
- concept (1)
- concordance (1)
- conservation (1)
- cryo-EM (1)
- dE/dx (1)
- detector (1)
- downgrading (1)
- e-Health (1)
- emergency care (1)
- epidemiology (1)
- everolimus (1)
- excipients (1)
- executive functions (1)
- exercise (1)
- exotic (1)
- experimental results (1)
- expertise (1)
- exponential model (1)
- fecal microbiota transfer (1)
- fibrotest (1)
- flow cytometry (1)
- fusion biopsy (1)
- graft-vs-host disease (1)
- health (1)
- heart-on-a-chip (1)
- heavy ion experiments (1)
- hemodynamic (1)
- hepatitis C (1)
- hiv (1)
- hospital admission (1)
- human allogeneic hematopoietic cell transplantation (1)
- human immunodeficiency virus (1)
- human intestinal microbiota (1)
- immune reconstitution (1)
- immunohistochemistry (1)
- impact (1)
- induction regimen (1)
- inflammation (1)
- invasion (1)
- ion‐induced nucleation (1)
- kidney (1)
- kidney-on-a-chip (1)
- lantibiotic (1)
- lapatinib (1)
- lenalidomide (1)
- lipoprotein (1)
- liver-on-a-chip (1)
- lockdowns (1)
- longitudinally extensive transverse myelitis (1)
- lung-on-a-chip (1)
- magnetic resonance imaging (1)
- male (1)
- management (1)
- mass spectrometry (1)
- mechanical ventilation (1)
- membrane proteins (1)
- metastatic (1)
- metastatic renal cell carcinoma (1)
- micro-physiological systems (1)
- molecular machines (1)
- mortality (1)
- multiple myeloma (1)
- native (1)
- neurodevelopment (1)
- nisin binding (1)
- non-invasive fibrosis assessment (1)
- nonnative (1)
- nuclear magnetic resonance (NMR) (1)
- organs-on-a-chip (1)
- pain (1)
- pertuzumab (1)
- phase IV (1)
- phylogeny (1)
- physical activity (1)
- pleiotropy (1)
- pneumocystis carinii (1)
- pneumocystis pneumonia (1)
- pneumonia (1)
- point shear wave elastography (1)
- prevention (1)
- primary active transporters (1)
- primary immunodeficiency (PID) (1)
- prognostic scores (1)
- prophylaxis (1)
- prostate cancer (1)
- prostate neoplasm (1)
- protein structure (1)
- psychological health (1)
- pulmonary failure (1)
- quark gluon plasma (1)
- radical prostatectomy (1)
- recurrent optic neuritis (1)
- registry for primary immunodeficiency (1)
- renal failure (1)
- respiratory failure (1)
- risk (1)
- second-line (1)
- seed and soil (1)
- sequence alignment (1)
- simulation (1)
- simulation training (1)
- skin-on-a-chip (1)
- small angle x-ray scattering (1)
- spectra (1)
- sphingolipid (1)
- spinal bone metastasis (1)
- stakeholder (1)
- structural biology (1)
- systematic biopsy (1)
- telemedicine (1)
- thrombolysis (1)
- thrombolysis (tPA) (1)
- training (1)
- transient elastography (1)
- trastuzumab (1)
- uncertainty (1)
- upgrading (1)
- valuation (1)
- working memory (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1163)
- Frankfurt Institute for Advanced Studies (FIAS) (1034)
- Informatik (997)
- Medizin (73)
- Geowissenschaften (12)
- Biochemie und Chemie (7)
- Biowissenschaften (5)
- Institut für Ökologie, Evolution und Diversität (4)
- ELEMENTS (3)
- Informatik und Mathematik (3)
We report on the production of inclusive Υ(1S) and Υ(2S) in p-Pb collisions at sNN−−−√=5.02 TeV at the LHC. The measurement is performed with the ALICE detector at backward (−4.46<ycms<−2.96) and forward (2.03<ycms<3.53) rapidity down to zero transverse momentum. The production cross sections of the Υ(1S) and Υ(2S) are presented, as well as the nuclear modification factor and the ratio of the forward to backward yields of Υ(1S). A suppression of the inclusive Υ(1S) yield in p-Pb collisions with respect to the yield from pp collisions scaled by the number of binary nucleon-nucleon collisions is observed at forward rapidity but not at backward rapidity. The results are compared to theoretical model calculations including nuclear shadowing or partonic energy loss effects.
The pT-differential production cross section of electrons from semileptonic decays of heavy-flavor hadrons has been measured at mid-rapidity in proton-proton collisions at s√=2.76 TeV in the transverse momentum range 0.5 < pT < 12 GeV/c with the ALICE detector at the LHC. The analysis was performed using minimum bias events and events triggered by the electromagnetic calorimeter. Predictions from perturbative QCD calculations agree with the data within the theoretical and experimental uncertainties.
The differential charged jet cross sections, jet fragmentation distributions, and jet shapes are measured in minimum bias proton-proton collisions at centre-of-mass energy s√=7 TeV using the ALICE detector at the LHC. Jets are reconstructed from charged particle momenta in the mid-rapidity region using the sequential recombination kT and anti-kT as well as the SISCone jet finding algorithms with several resolution parameters in the range R=0.2 to 0.6. Differential jet production cross sections measured with the three jet finders are in agreement in the transverse momentum (pT) interval 20<pjet,chT<100 GeV/c. They are also consistent with prior measurements carried out at the LHC by the ATLAS collaboration. The jet charged particle multiplicity rises monotonically with increasing jet pT, in qualitative agreement with prior observations at lower energies. The transverse profiles of leading jets are investigated using radial momentum density distributions as well as distributions of the average radius containing 80% (⟨R80⟩) of the reconstructed jet pT. The fragmentation of leading jets with R=0.4 using scaled pT spectra of the jet constituents is studied. The measurements are compared to model calculations from event generators (PYTHIA, PHOJET, HERWIG). The measured radial density distributions and ⟨R80⟩ distributions are well described by the PYTHIA model (tune Perugia-2011). The fragmentation distributions are better described by HERWIG.
The Transition Radiation Detector (TRD) was designed and built to enhance the capabilities of the ALICE detector at the Large Hadron Collider (LHC). While aimed at providing electron identification and triggering, the TRD also contributes significantly to the track reconstruction and calibration in the central barrel of ALICE. In this paper the design, construction, operation, and performance of this detector are discussed. A pion rejection factor of up to 410 is achieved at a momentum of 1 GeV/c in p–Pb collisions and the resolution at high transverse momentum improves by about 40% when including the TRD information in track reconstruction. The triggering capability is demonstrated both for jet, light nuclei, and electron selection.
The first measurement of ϕ-meson production in p-Pb collisions at a nucleon-nucleon centre-of-mass energy sNN−−−√ = 5.02 TeV has been performed with the ALICE apparatus at the LHC. The ϕ-mesons have been identified in the dimuon decay channel in the transverse momentum (pT) range 1<pT<7 GeV/c, both in the p-going (2.03<y<3.53) and the Pb-going (−4.46<y<−2.96) directions, where y stands for the rapidity in the nucleon-nucleon centre-of-mass. Differential cross sections as a function of transverse momentum and rapidity are presented. The forward-backward asymmetry for ϕ-meson production is measured for 2.96<|y|<3.53, resulting in a factor ∼0.5 with no significant pT dependence within the uncertainties. The pT dependence of the ϕ nuclear modification factor RpPb exhibits an enhancement up to a factor 1.6 at pT = 3-4 GeV/c in the Pb-going direction. The pT dependence of the ϕ-meson cross section in pp collisions at s√ = 2.76 TeV, which is used to determine a reference for the p-Pb results, is also presented here for 1<pT<5 GeV/c and 2.5<y<4.
We report on results obtained with the Event Shape Engineering technique applied to Pb-Pb collisions at sNN−−−√=2.76 TeV. By selecting events in the same centrality interval, but with very different average flow, different initial state conditions can be studied. We find the effect of the event-shape selection on the elliptic flow coefficient v2 to be almost independent of transverse momentum pT, as expected if this effect is due to fluctuations in the initial geometry of the system. Charged hadron, pion, kaon, and proton transverse momentum distributions are found to be harder in events with higher-than-average elliptic flow, indicating an interplay between radial and elliptic flow.
Transverse momentum (pT) spectra of pions, kaons, and protons up to pT=20 GeV/c have been measured in Pb-Pb collisions at sNN−−−√=2.76 TeV using the ALICE detector for six different centrality classes covering 0-80%. The proton-to-pion and the kaon-to-pion ratios both show a distinct peak at pT≈3 GeV/c in central Pb-Pb collisions that decreases towards more peripheral collisions. For pT>10 GeV/c, the nuclear modification factor is found to be the same for all three particle species in each centrality interval within systematic uncertainties of 10-20%. This suggests there is no direct interplay between the energy loss in the medium and the particle species composition in the hard core of the quenched jet. For pT<10 GeV/c, the data provide important constraints for models aimed at describing the transition from soft to hard physics.
Transverse momentum (pT) spectra of pions, kaons, and protons up to pT=20 GeV/c have been measured in Pb-Pb collisions at sNN−−−√=2.76 TeV using the ALICE detector for six different centrality classes covering 0-80%. The proton-to-pion and the kaon-to-pion ratios both show a distinct peak at pT≈3 GeV/c in central Pb-Pb collisions that decreases towards more peripheral collisions. For pT>10 GeV/c, the nuclear modification factor is found to be the same for all three particle species in each centrality interval within systematic uncertainties of 10-20%. This suggests there is no direct interplay between the energy loss in the medium and the particle species composition in the hard core of the quenched jet. For pT<10 GeV/c, the data provide important constraints for models aimed at describing the transition from soft to hard physics.
The first study of ϕ-meson production in p-Pb collisions at forward and backward rapidity, at a nucleon-nucleon centre-of-mass energy sNN−−−√=5.02~TeV, has been performed with the ALICE apparatus at the LHC. The ϕ-mesons have been identified in the dimuon decay channel in the transverse momentum (pT) range 1<pT<7 GeV/c, both in the p-going (2.03<y<3.53) and the Pb-going (−4.46<y<−2.96) directions, where y stands for the rapidity in the nucleon-nucleon centre-of-mass, the integrated luminosity amounting to 5.01±0.19~nb−1 and 5.81±0.20~nb−1, respectively, for the two data samples. Differential cross sections as a function of transverse momentum and rapidity are presented. The forward-backward ratio for ϕ-meson production is measured for 2.96<|y|<3.53, resulting in a ratio ∼0.5 with no significant pT dependence within the uncertainties. The pT dependence of the ϕ nuclear modification factor RpPb exhibits an enhancement up to a factor 1.6 at pT = 3-4 GeV/c in the Pb-going direction. The pT dependence of the ϕ-meson cross section in pp collisions at s√ = 2.76 TeV, which is used to determine a reference for the p-Pb results, is also presented here for 1<pT<5 GeV/c and 2.5<y<4 for a 78±3~nb−1 integrated luminosity sample.
The first study of ϕ-meson production in p-Pb collisions at forward and backward rapidity, at a nucleon-nucleon centre-of-mass energy sNN−−−√=5.02~TeV, has been performed with the ALICE apparatus at the LHC. The ϕ-mesons have been identified in the dimuon decay channel in the transverse momentum (pT) range 1<pT<7 GeV/c, both in the p-going (2.03<y<3.53) and the Pb-going (−4.46<y<−2.96) directions, where y stands for the rapidity in the nucleon-nucleon centre-of-mass, the integrated luminosity amounting to 5.01±0.19~nb−1 and 5.81±0.20~nb−1, respectively, for the two data samples. Differential cross sections as a function of transverse momentum and rapidity are presented. The forward-backward ratio for ϕ-meson production is measured for 2.96<|y|<3.53, resulting in a ratio ∼0.5 with no significant pT dependence within the uncertainties. The pT dependence of the ϕ nuclear modification factor RpPb exhibits an enhancement up to a factor 1.6 at pT = 3-4 GeV/c in the Pb-going direction. The pT dependence of the ϕ-meson cross section in pp collisions at s√ = 2.76 TeV, which is used to determine a reference for the p-Pb results, is also presented here for 1<pT<5 GeV/c and 2.5<y<4 for a 78±3~nb−1 integrated luminosity sample.